Dir
Cam Gallagher, MBA, is a seasoned biotechnology executive with over 30 years of experience in the life sciences industry, specializing in new company formation, corporate development, marketing, operations, and early-stage investing.[[1]](https://opusgtx.com/team/cam-gallagher-mba/)[[2]](https://www.xlinktx.com/team-members/cam-gallagher-mba/) He currently serves as President and CEO of Alessa Therapeutics, a clinical-stage drug development company focused on localized drug delivery for prostate cancer, and as a board member for Opus Genetics, Inc. (NASDAQ: IRD), where he has been a director since January 2019 and Chair since December 2019; he also sits on the boards of SelectION, Immusoft, and UC San Diego Moores Cancer Center.[[1]](https://opusgtx.com/team/cam-gallagher-mba/)[[2]](https://www.xlinktx.com/team-members/cam-gallagher-mba/)[[4]](https://ir.opusgtx.com/corporate-governance)[[5]](https://opusgtx.com/about/board-of-directors/)
Gallagher's career highlights include co-founding and serving as President and board member of Zentalis Pharmaceuticals (NASDAQ: ZNTL) from 2014 to 2024, Chief Business Officer at RetroSense Therapeutics (acquired by Allergan in 2016), and founding board member at VelosBio (acquired by Merck for $2.8B in 2020).[[1]](https://opusgtx.com/team/cam-gallagher-mba/)[[2]](https://www.xlinktx.com/team-members/cam-gallagher-mba/) He co-founded Nerveda, LLC, a life science seed fund, and held management roles at Oncternal, Zavante, Verus Pharma, CV Therapeutics, and Dura Pharma. Gallagher recently purchased 83,000 shares of Opus Genetics stock on December 29, 2025, at $1.97 per share, signaling confidence in the company.[[3]](https://www.marketbeat.com/instant-alerts/opus-genetics-nasdaqird-director-cam-gallagher-purchases-83000-shares-2025-12-31/) He holds an MBA from the University of San Diego and a BS (or BBA) in Business Administration from Ohio University.[[1]](https://opusgtx.com/team/cam-gallagher-mba/)[[2]](https://www.xlinktx.com/team-members/cam-gallagher-mba/)
View full insider profile →